BIOMAT Database Logo BIOMAT Database Logo

Laboratory control, optimal therapeutic ranges and therapeutic quality control in oral anticoagulation. 1985

E A Loeliger

UI MeSH Term Description Entries
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D011786 Quality Control A system for verifying and maintaining a desired level of quality in a product or process by careful planning, use of proper equipment, continued inspection, and corrective action as required. (Random House Unabridged Dictionary, 2d ed) Control, Quality,Controls, Quality,Quality Controls
D002138 Calibration Determination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output. Calibrations
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D013925 Thromboplastin Constituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation. Antigens, CD142,CD142 Antigens,Coagulation Factor III,Factor III,Tissue Factor,Tissue Thromboplastin,Blood Coagulation Factor III,Coagulin,Glomerular Procoagulant Activity,Prothrombinase,Tissue Factor Procoagulant,Urothromboplastin,Activity, Glomerular Procoagulant,Factor III, Coagulation,Procoagulant Activity, Glomerular,Procoagulant, Tissue Factor,Thromboplastin, Tissue

Related Publications

E A Loeliger
Therapeutic ranges for oral anticoagulation in different thromboembolic disorders.
February 1992, Annals of hematology,
E A Loeliger
[Laboratory control of oral anticoagulation].
January 1995, Revista da Associacao Medica Brasileira (1992),
E A Loeliger
Quality control and oral anticoagulation.
July 1995, Thrombosis and haemostasis,
E A Loeliger
Therapeutic quality control leading to further clinical assessment of oral anticoagulation.
January 1986, Acta haematologica,
E A Loeliger
[Control of oral anticoagulation--therapeutic range].
September 1977, Schweizerische medizinische Wochenschrift,
E A Loeliger
[Control of oral anticoagulation. The therapeutic range].
May 1977, Therapeutische Umschau. Revue therapeutique,
E A Loeliger
[Therapeutic quality control of follow-up of oral anticoagulation in primary care: 4-year experience].
May 1995, Atencion primaria,
E A Loeliger
[Laboratory and therapeutic control of oral anticoagulant treatment].
January 1987, Annali dell'Ospedale Maria Vittoria di Torino,
E A Loeliger
[Most frequent errors in the laboratory control of oral anticoagulation (author's transl)].
May 1977, Therapeutische Umschau. Revue therapeutique,
E A Loeliger
Letter: Reliability of laboratory tests for the control of oral anticoagulation.
April 1975, Thrombosis et diathesis haemorrhagica,
Copied contents to your clipboard!